Next Article in Journal
Impedance Cardiography and Heart Rate Variability for Long-Term Cardiovascular Outcome Prediction After Myocardial Infarction
Previous Article in Journal
Recent Advances in Endovascular Treatment of Aortoiliac Occlusive Disease
 
 
Medicina is published by MDPI from Volume 54 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Lithuanian Medical Association, Lithuanian University of Health Sciences, and Vilnius University.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas

by
Paulina Vaitkienė
*,
Daina Skiriutė
,
Kęstutis Skauminas
and
Arimantas Tamašauskas
Laboratory of Neurooncology and Genetics, Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Lithuania
*
Author to whom correspondence should be addressed.
Medicina 2012, 48(7), 51; https://doi.org/10.3390/medicina48070051
Submission received: 5 March 2012 / Accepted: 30 July 2012 / Published: 4 August 2012

Abstract

Background and Objective. The epigenetic silencing of tumor suppressor genes plays an important role in gliomagenesis. Recently, tissue factor pathway inhibitor 2 (TFPI-2) has been suggested as a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. However, to date, little is known about the methylation status of TFPI-2 gene in glioblastoma tissues. In this study, we aimed to investigate the methylation status of TFPI-2 promoter and its associations with patient prognosis in glioblastoma.
Material and Methods
. The methylation status of TFPI-2 was investigated by methylationspecific polymerase chain reaction in 99 glioblastoma patients. The associations between patients’ clinical variables and overall survival time were assessed.
Results
. TFPI-2 was aberrantly methylated in 22.2% (22/99) of glioblastoma tumors, but was not methylated in normal brain samples. The survival of patients with glioblastoma differed significantly between the methylated and unmethylated TFPI-2 groups (P=0.047). The 2-year survival among patients carrying methylated TFPI-2 tumors was significantly lower compared with that of patients with unmethylated TFPI-2 (27% versus 4.7%, P=0.037).
Conclusions
. The present work demonstrated that the epigenetic inactivation of TFPI-2 by promoter hypermethylation was a frequent and tumor-specific event in glioblastoma, and TFPI-2 promoter methylation might be considered as a prognostic marker in glioblastoma.
Keywords: glioblastoma; tissue factor pathway inhibitor 2; methylation; survival glioblastoma; tissue factor pathway inhibitor 2; methylation; survival

Share and Cite

MDPI and ACS Style

Vaitkienė, P.; Skiriutė, D.; Skauminas, K.; Tamašauskas, A. Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas. Medicina 2012, 48, 51. https://doi.org/10.3390/medicina48070051

AMA Style

Vaitkienė P, Skiriutė D, Skauminas K, Tamašauskas A. Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas. Medicina. 2012; 48(7):51. https://doi.org/10.3390/medicina48070051

Chicago/Turabian Style

Vaitkienė, Paulina, Daina Skiriutė, Kęstutis Skauminas, and Arimantas Tamašauskas. 2012. "Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas" Medicina 48, no. 7: 51. https://doi.org/10.3390/medicina48070051

APA Style

Vaitkienė, P., Skiriutė, D., Skauminas, K., & Tamašauskas, A. (2012). Associations Between TFPI-2 Methylation and Poor Prognosis in Glioblastomas Paulina Vaitkienė, Daina Skiriutė, Kęstutis Skauminas. Medicina, 48(7), 51. https://doi.org/10.3390/medicina48070051

Article Metrics

Back to TopTop